UBS AM’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

UBS AM’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-93,748	Closed	-$237K	–	2588
2023 Q4	$237K	Sell	93,748 -131,453	-58%	-$306K	﹤0.01%	2466
2023 Q3	$538K	Buy	225,201 +25,200	+13%	+$55.8K	﹤0.01%	2264
2023 Q2	$510K	Hold	200,001	–	–	﹤0.01%	2312
2023 Q1	$510K	Hold	200,001	–	–	﹤0.01%	2312
2022 Q4	$502K	Buy	200,001 +101,683	+103%	+$284K	﹤0.01%	2174
2022 Q3	$285K	Buy	98,318 +19,082	+24%	+$80.3K	﹤0.01%	2506
2022 Q2	$358K	Buy	+79,236	New	+$471K	﹤0.01%	2413

UBS AM's SLGC Position: Q1 2024 in Review

UBS AM sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 93,748 shares — an estimated $237K sold.

UBS AM first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $538K in Q3 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

UBS AM reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
UBS AM sold 93,748 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $237K.
UBS AM first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
UBS AM's SomaLogic, Inc. Class A Common Stock position peaked at $538K in Q3 2023.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on UBS AM's 13F filing for Q1 2024, filed 15 May 2024.